Page last updated: 2024-08-24

2,4-diaminopyridine and Local Neoplasm Recurrence

2,4-diaminopyridine has been researched along with Local Neoplasm Recurrence in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allen, A; Chaturvedi, P; Dubrovskiy, A; Etter, J; Harding, TC; Haringsma, H; Karp, R; Labenski, MT; Lee, K; Martin, TS; Medikonda, A; Nacht, M; Niu, D; Petter, RC; Raponi, M; Ren, Y; Sheets, M; Simmons, AD; Singh, J; Tester, R; Tjin Tham Sjin, R; Walter, AO; Westlin, WF; Zhu, Z1

Other Studies

1 other study(ies) available for 2,4-diaminopyridine and Local Neoplasm Recurrence

ArticleYear
In vitro and in vivo characterization of irreversible mutant-selective EGFR inhibitors that are wild-type sparing.
    Molecular cancer therapeutics, 2014, Volume: 13, Issue:6

    Topics: 4-Aminopyridine; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Clinical Trials as Topic; Drug Resistance, Neoplasm; ErbB Receptors; Humans; In Vitro Techniques; Mice; Mutation; Neoplasm Recurrence, Local; Xenograft Model Antitumor Assays

2014